Pangaea Oncology Future Growth
Future criteria checks 0/6
Pangaea Oncology is forecast to grow earnings and revenue by 88.6% and 4.4% per annum respectively.
Key information
88.6%
Earnings growth rate
n/a
EPS growth rate
| Life Sciences earnings growth | 26.2% |
| Revenue growth rate | 4.4% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 04 Nov 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 16 | 0 | 0 | 0 | 1 |
| 12/31/2025 | 15 | -1 | -1 | -1 | 1 |
| 12/31/2024 | 14 | -1 | -2 | -2 | 1 |
| 6/30/2024 | 14 | -5 | -3 | -3 | N/A |
| 3/31/2024 | 12 | -5 | -3 | -3 | N/A |
| 12/31/2023 | 10 | -5 | -3 | -2 | N/A |
| 9/30/2023 | 8 | -4 | -3 | -3 | N/A |
| 6/30/2023 | 6 | -3 | -4 | -3 | N/A |
| 3/31/2023 | 7 | -3 | -4 | -4 | N/A |
| 12/31/2022 | 7 | -3 | -4 | -4 | N/A |
| 9/30/2022 | 7 | -2 | -3 | -3 | N/A |
| 6/30/2022 | 7 | -2 | -3 | -3 | N/A |
| 3/31/2022 | 7 | -1 | -3 | -3 | N/A |
| 12/31/2021 | 7 | -1 | -3 | -3 | N/A |
| 9/30/2021 | 7 | -1 | -2 | -2 | N/A |
| 6/30/2021 | 7 | -1 | -2 | -2 | N/A |
| 3/31/2021 | 6 | -1 | -2 | -2 | N/A |
| 12/31/2020 | 6 | -2 | -2 | -2 | N/A |
| 9/30/2020 | 6 | -3 | -2 | -2 | N/A |
| 6/30/2020 | 6 | -4 | -3 | -3 | N/A |
| 3/31/2020 | 6 | -4 | -3 | -2 | N/A |
| 12/31/2019 | 6 | -5 | -2 | -2 | N/A |
| 9/30/2019 | 6 | -3 | -2 | -2 | N/A |
| 6/30/2019 | 5 | -2 | -1 | -1 | N/A |
| 3/31/2019 | 6 | -1 | -2 | -2 | N/A |
| 12/31/2018 | 6 | -1 | -2 | -2 | N/A |
| 9/30/2018 | 6 | -2 | -4 | -3 | N/A |
| 6/30/2018 | 6 | -2 | -5 | -5 | N/A |
| 3/31/2018 | 6 | -2 | N/A | -6 | N/A |
| 12/31/2017 | 6 | -2 | N/A | -6 | N/A |
| 9/30/2017 | 6 | -1 | N/A | -5 | N/A |
| 6/30/2017 | 5 | -1 | N/A | -4 | N/A |
| 3/31/2017 | 5 | -1 | N/A | -3 | N/A |
| 12/31/2016 | 5 | -1 | N/A | -2 | N/A |
| 9/30/2016 | 5 | -1 | N/A | -2 | N/A |
| 6/30/2016 | 5 | 0 | N/A | -2 | N/A |
| 3/31/2016 | 4 | 0 | N/A | -2 | N/A |
| 12/31/2015 | 4 | 0 | N/A | -2 | N/A |
| 12/31/2014 | 2 | 0 | N/A | -2 | N/A |
| 12/31/2013 | 3 | 0 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PANG is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PANG is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PANG is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PANG's revenue (4.4% per year) is forecast to grow slower than the Spanish market (4.9% per year).
High Growth Revenue: PANG's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PANG's Return on Equity is forecast to be high in 3 years time